Francisco Jesús V. M.
- Country
- Spain
- Department
- Servicio Medicina Interna
Research Overview
- Efficacy and Safety of Islatravir and Ulonivirine Once Weekly versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Once Daily in Treatment-Naïve Adults with HIV-1
- Phase III Randomized, Double-Blind Study of Dexamethasone and Oseltamivir Versus Placebo in Patients with Severe Influenza
- Long Acting Cabotegravir plus Rilpivirine in People Living with HIV-1 (PLHIV) Aged ≥ 60 Years for 96 weeks.
Data & Insights
Has run more than one trial at 5 of 66 partner sites.
Specializations
Respiratory Infections
The investigator specializes in treating severe influenza, with particular focus on exploring therapeutic interventions for hospitalized patients requiring supplemental oxygen or intensive care support.
- Advanced respiratory support protocols
- Critical care management
- Therapeutic interventions for severe influenza
Their research extends to evaluating treatment outcomes in patients requiring various levels of respiratory support.
Viral Infections
This investigator focuses on treating COVID-19 in non-hospitalized patients, particularly those at elevated risk for severe illness. Their expertise includes evaluating antiviral interventions and monitoring disease progression.
- Outpatient COVID-19 management
- High-risk patient care
- Prevention of disease progression
Their work encompasses comprehensive assessment of treatment efficacy and patient safety in viral infections.
Infectious Diseases
The investigator specializes in treating HIV-1 infection, with particular emphasis on managing treatment in older adults. Their expertise includes long-acting therapeutic approaches and antiretroviral therapy optimization.
- HIV treatment in elderly populations
- Long-acting therapeutic strategies
- Viral load management
Their research focuses on innovative treatment approaches for aging populations with HIV.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.